The nature of the TCR interaction with foreign peptide--MHC (pMHC) complexes dictates the response magnitude and differentiation characteristics of antigen specific T cells^[@R1]--[@R4]^. In addition studies suggest TCR interactions with self-pMHC also impact the naïve T cell response to foreign-pMHC^[@R5]--[@R11]^. Thymic positive selection and naïve T cell homeostasis require low affinity TCR recognition of self-pMHC ligands^[@R12]--[@R16]^, but there is controversy about how such interactions affect the subsequent response to foreign-pMHC: published studies argue self-pMHC recognition enhances^[@R6]^ or diminishes^[@R7]^ the response to foreign antigens, or selectively impairs sensitivity to low-affinity foreign ligands^[@R14]^. However, those reports investigated the impact of self-pMHC withdrawal rather than studying how the degree of self-pMHC sensitivity influences the T cell response to foreign-pMHC.

Homeostatic TCR interactions with self-pMHC are thought to be of very low affinity and involve recognition of multiple self-peptides by an individual T cell clone, precluding direct assessment of self-pMHC recognition characteristics in the polyclonal T cell pool. However, differences in the expression of the cell surface protein CD5 have proven to be a valuable surrogate for the strength of the TCR-self-pMHC interactions^[@R14],[@R17]--[@R21]^. CD5 expression on naïve T cells accurately predicts basal TCR signaling intensity and the capacity of T cells to rapidly engage key TCR signaling pathways^[@R9]--[@R11]^, and correlates with the ability of naïve CD8^+^ T cells to respond to homeostatic cues^[@R22]--[@R26]^. However, the underlying basis for the distinct response characteristics of naïve CD5^lo^ and CD5^hi^ populations is unclear, as is the impact of these differences on reactivity toward foreign-pMHC.

Recent studies used CD5 expression on naïve CD4^+^ T cells to correlate the strength of self-pMHC interaction with foreign-pMHC reactivity^[@R9]--[@R11]^. In one study, analysis of TCR transgenic mice suggested a direct correlation between the abundance of cell surface CD5 and the ability to bind cognate foreign-pMHC tetramers^[@R9]^, suggesting TCR affinity for self-pMHC predicts the affinity for foreign-pMHC. Those authors observed more vigorous responses by CD5^hi^ than CD5^lo^ naïve CD4^+^ T cells toward foreign-pMHC. Another report failed to observe any correlation between CD5 expression and TCR affinity for foreign-pMHC ligands, however, and found that CD5^lo^ T cells expanded more efficiently than CD5^hi^ cells during the primary response to foreign antigen^[@R10],[@R11]^. Hence, whether and how CD5 expression predicts the capacity of naïve T cells to bind to and/or respond toward foreign-pMHC ligands is unclear.

Here, we report that CD5^hi^ and CD5^lo^ naïve CD8^+^ T cells differ in gene expression characteristics and that the CD5^hi^ population manifests improved clonal recruitment and expansion in response to foreign-pMHC. These response differences did not correlate with the strength of the TCR interaction with foreign-pMHC, but CD5^hi^ naïve CD8^+^ T cells showed superior utilization of *in vivo* inflammatory signals. Our data suggest pre-determined heterogeneity among naïve T cells dictates their capacity to respond to foreign antigens, with consequences for diversity of the functional T cell repertoire. Moreover, the finding that T cells with strong reactivity toward self-pMHC dominate the foreign-pMHC response has implications for outgrowth of autoreactive T cells.

Results {#S1}
=======

Distinct phenotype of CD5^hi^ and CD5^lo^ CD8^+^ T cells {#S2}
--------------------------------------------------------

We first examined phenotypic differences between naïve (CD44^lo^CD122^lo^) CD5^lo^ and CD5^hi^ CD8^+^ T cells. Extending previous work^[@R24],[@R26],[@R27]^ CD5^hi^ cells were slightly larger, had elevated expression of CD44 and modestly increased interleukin 2Rβ (CD122) and IL-7Rα (CD127) expression, but slightly lower TCR, CD8^+^ and CD62L expression compared to the CD5^lo^ population ([Fig. 1a](#F1){ref-type="fig"}, [Supplementary Fig. 1a--c](#SD1){ref-type="supplementary-material"}). The CD5^hi^ naïve CD8^+^ T cell population also showed elevated expression of T-bet and eomesodermin (transcription factors associated with activated CD8^+^ T cell differentiation^[@R28]^) and a subset of CD5^hi^ cells expressed the chemokine receptor CXCR3 ([Fig. 1a](#F1){ref-type="fig"}). The phenotypic characteristics of CD5^hi^ naïve CD8^+^ T cells had some similarities to memory CD8^+^ T cells. However, the frequency and phenotype of CD5^hi^ naïve CD8^+^ T cells was similar in IL-15-deficient mice, which lack typical CD8^+^ memory T cells^[@R29]^ ([Fig. 1b](#F1){ref-type="fig"} and [Supplementary Fig. 1b,c](#SD1){ref-type="supplementary-material"}). Hence, the CD5^hi^ naïve CD8^+^ T cell population neither derives from nor depends on memory-phenotype CD8^+^ T cells.

To determine whether the CD5^hi^ and CD5^lo^ populations are stable, we sorted polyclonal naïve CD8^+^ T cells into CD5^hi^ and CD5^lo^ populations (reflecting the upper and lower 20% of CD5 distribution, respectively), and congenically distinct cell populations were co-transferred into normal recipients. Both transferred populations maintained distinct CD5 expression and persisted for at least 8 weeks, indicating equivalent steady state survival (similar to studies on naïve CD4^+^ T cells^[@R9]^) ([Fig. 1c,d](#F1){ref-type="fig"} **and data not shown**). The majority of donor cells maintained a naïve phenotype, though a fraction of CD5^hi^ cells converted to CD44^hi^ phenotype ([Supplementary Fig. 1d](#SD1){ref-type="supplementary-material"}), consistent with their enhanced response to homeostatic cues^[@R22]--[@R26]^.

Biochemical approaches indicate a correlation between CD5 abundance and the degree of basal TCR signaling^[@R5],[@R9],[@R11]^, however such methods cannot permit assessment of TCR signal strength in individual cells. Hence we examined Nur77^gfp^ transgenic reporter mice, in which green fluorescent protein (GFP) expression provides a sensitive readout of TCR signaling^[@R30]^. For CD8^+^ and CD4^+^ naïve T cell subsets, CD5^hi^ cells showed increased GFP expression compared to the CD5^lo^ population ([Fig. 1e](#F1){ref-type="fig"}), and this correlation held for Nur77^gfp^ expression in H-Y and OT-I TCR transgenic CD8^+^ T cells (which reflect CD5^lo^ and CD5^hi^ populations, respectively)^[@R9],[@R22],[@R25]^ ([Fig. 1f](#F1){ref-type="fig"}). Thus, CD5^hi^ and CD5^lo^ naïve CD8^+^ T cells are distinct, stable populations, with CD5^hi^ cells displaying characteristics of cells that undergo more intense or frequent TCR interactions with self-pMHC.

Distinct transcriptional profiles of CD5^hi^ and CD5^lo^ CD8^+^ T cells {#S3}
-----------------------------------------------------------------------

We next conducted gene expression analysis on polyclonal CD5^hi^ and CD5^lo^ naïve CD8^+^ T cells. In total, 57 unique genes were significantly changed by at least 2-fold (47 upregulated, 10 downregulated) in CD5^hi^ relative to CD5^lo^ naïve CD8^+^ T cells ([Table 1](#T1){ref-type="table"}). Among genes upregulated in CD5^hi^ cells were those for the transcription factors Eomes, T-bet, Helios and Id3, many of which play a key role in activated T cell differentiation^[@R28]^, and molecules associated with trafficking and adhesion of effector T cells (CXCR3, XCL1 and CD44). Conversely, the kinase Itk (which can serve as a negative regulator of T-bet^[@R31],[@R32]^) was downregulated in CD5^hi^ cells.

We further investigated the expression of XCL1, since it has been associated with efficient *in vivo* activation of CD8^+^ T cells (via enhancing T cell-dendritic cell colocalization)^[@R33]^. After brief *in vitro* stimulation of splenocytes, XCL1 protein expression was biased to a sub-population of CD5^hi^ naïve CD8+ T cells ([Fig. 2a,b](#F2){ref-type="fig"}; [Supplementary Fig. 2a](#SD1){ref-type="supplementary-material"}). Expression of CXCR3 and T-bet also marked a subset of CD5^hi^ naïve CD8^+^ T cells ([Fig. 2b](#F2){ref-type="fig"})([Supplementary Fig. 2a](#SD1){ref-type="supplementary-material"}). However, although memory phenotype (CD44^hi^) CD8^+^ T cells typically co-expressed these proteins, there was little coordinated expression in the naïve CD5^hi^ pool ([Supplementary Fig. 2b,c](#SD1){ref-type="supplementary-material"}), indicating considerable heterogeneity within the CD5^hi^ naïve CD8^+^ T cell population.

Most individual gene expression differences between CD5^hi^ and CD5^lo^ naïve CD8^+^ T cell populations were subtle ([Table 1](#T1){ref-type="table"}), hence we explored whether there were changes in expression of gene sets. For a focused comparison, we used a χ^2^ test to align differences in CD5^hi^ and CD5^lo^ transcription with a database generated by ImmGen Consortium (Immgen.org), which had comprehensively defined patterns of gene expression following activation and differentiation of CD8^+^ T cells^[@R34]^. In that earlier work, a temporal analysis of gene expression over the course of the immune response allowed for the characterization of 10 clusters of correlated gene expression^[@R34]^. We investigated how expression of genes in these clusters were regulated in the CD5^hi^ and CD5^lo^ naïve CD8^+^ T cell subsets. This analysis revealed that the CD5^hi^ population expressed significantly higher proportion of genes that characterize two early stages of the CD8^+^ T cell response and are associated with preparation for cell cycle (Cluster II) and active cell cycle and division (Cluster III) ([Fig. 2c](#F2){ref-type="fig"}, [Table 2](#T2){ref-type="table"}). A more moderate (but still highly significant) correlation with Cluster X, which defines genes expressed at late effector and memory stages ([Fig. 2c](#F2){ref-type="fig"}, [Table 2](#T2){ref-type="table"}). Together, these data suggest the CD5^hi^ population is better poised for initial activation, compared to the CD5^lo^ population.

Enhanced expansion of CD5^hi^ CD8^+^ T cells in response to infection {#S4}
---------------------------------------------------------------------

We next directly tested whether CD5^hi^ and CD5^lo^ naïve CD8^+^ T cells differ in their primary immune response against foreign antigen. In initial studies we assayed polyclonal CD8^+^ T cells specific for the H-2K^b^ restricted vaccinia virus epitope B8R~20--27~ (B8R), which are present at a frequency of \~1 per 1--2 × 10^4^ CD8^+^ T cells in unimmunized C57BL/6 mice^[@R35]^. Naïve CD44^lo^ CD8^+^ T cells were sorted by flow cytometry into congenically distinct CD5^lo^ and CD5^hi^ populations, and \~1.5 × 10^6^ of each population co-transferred into recipients that were subsequently infected with LM-B8R, a recombinant attenuated *Listeria monocytogenes* expressing the B8R~20--27~ and the H-2K^b^ restricted ovalbumin peptide (OVA~257--264~: Ova). Assuming \~20% engraftment following adoptive transfer, this should seed \~20 B8R/K^b^ specific cells from each donor. At day 7 following infection, pMHC tetramer staining was used to identify responsive CD5^hi^ and CD5^lo^ donor cells, and the ratio ([Fig. 3a](#F3){ref-type="fig"}) and absolute numbers ([Fig. 3b](#F3){ref-type="fig"}) of each population was determined. In most cases, the CD5^hi^ donor population dominated the response, on average accounting of \~95% of the B8R/K^b^-specific population ([Fig. 3a,b](#F3){ref-type="fig"}), although occasionally progeny of the CD5^lo^ donors were more frequent (double dagger symbol in [Fig. 3a,b](#F3){ref-type="fig"}). Tetramer binding may fail to identify all functionally responsive cells but similar results were obtained using peptide-induced interferon-γ (IFN-γ) production to identify antigen specific T cells ([Supplementary Fig. 3a,b](#SD1){ref-type="supplementary-material"}). At memory phase following priming and also during a recall response, the progeny of CD5^hi^ donor cells maintained dominance over those from the CD5^lo^ pool ([Fig. 3a](#F3){ref-type="fig"}). The fact that this skewing was not exacerbated during the recall response indicates memory cells generated from CD5^lo^ and CD5^hi^ cells had similar re-expansion potential.

The dominance of CD5^hi^ naïve CD8^+^ T cell responses was not unique to B8R/K^b^ specific T cells or to Listeria infection: The OVA/K^b^ specific response induced by LM-B8R infection and the gp33/D^b^ specific response induced by lymphocytic choriomeningitis virus (LCMV) infection were also biased to the CD5^hi^ donor cells ([Supplementary Fig. 3c,d](#SD1){ref-type="supplementary-material"}). Beyond individual antigen specificities, the bulk pathogen-specific response -- identified as donor CD8^+^ T cells that had acquired an antigen-experienced CD44^hi^, CD8^lo^, CD11a^hi^ phenotype -- also showed an advantage for the CD5^hi^ donor pool, albeit less pronounced than observed for individual pMHC specific responses ([Fig. 3c](#F3){ref-type="fig"}, [Supplementary Fig. 3e](#SD1){ref-type="supplementary-material"}).

The preferential expansion of the CD5^hi^ donor population did not reflect greater intrinsic capacity of these cells for TCR-induced proliferation, as CD5^lo^ and CD5^hi^ naïve CD8^+^ T cells proliferated similarly upon *in vitro* stimulation with anti-CD3 plus anti-CD28 ([Supplementary Fig. 3f](#SD1){ref-type="supplementary-material"}), consistent with earlier studies^[@R9],[@R20],[@R24]^. The enhanced CD5^hi^ T cell B8R/K^b^-specific response was also seen when using *Rag-1*^−/−^ recipient mice, ruling out a required contribution of host T or B lymphocytes ([Supplementary Fig. 3g](#SD1){ref-type="supplementary-material"}).

Since naïve CD5^hi^ cells express intermediate amounts of CD44, it was formally possible that some memory-phenotype T cells had contaminated the CD5^hi^ donor population. Yet when CD5^hi^ and CD5^lo^ donor populations were sorted to have equally low CD44 expression, the CD5^hi^ donor population still dominated the response to LM-B8R ([Supplementary Fig. 3h](#SD1){ref-type="supplementary-material"}), arguing against memory cell contamination in our studies. The differential response of CD5^hi^ and CD5^lo^ naïve CD8^+^ T cells suggested that reactivity improves proportionally to increasing CD5 expression. To explore this, we measured the response to infection of CD5^lo^ and CD5^hi^ populations relative to total naïve CD8^+^ T cell pool (containing the full spectrum of CD5 expression). The CD5^lo^ population expanded less than bulk naïve CD8^+^ T cells, while the CD5^hi^ cells proliferated more ([Fig. 3d,e](#F3){ref-type="fig"}), suggesting that CD5^lo^ and CD5^hi^ populations represent the extremes of a continuum in reactivity to foreign antigen.

Given that the CD5^hi^ population is heterogeneous ([Fig. 2b](#F2){ref-type="fig"}, [Supplementary Fig. 2c](#SD1){ref-type="supplementary-material"}), it was possible that a small subset within this pool was responsible for their superior antigen-specific responses. We investigated this hypothesis by subdividing the naïve CD5^hi^ population based on CXCR3 expression, since this chemokine receptor has been associated with enhanced *in vivo* antigen detection by memory CD8^+^ T cells^[@R36],[@R37]^. We sorted congenic populations of naïve CD5^hi^ cells into CXCR3^lo^ and CXCR3^hi^ populations, and tested their response toward LM-B8R infection using the co-transfer model described above. We observed that expansion of the CXCR3^hi^ CD5^hi^ population was significantly greater than that of the CXCR3^lo^ CD5^hi^ subset, in both the B8R/K^b^ specific and bulk CD44^hi^ responder populations ([Fig. 3f](#F3){ref-type="fig"}). However, these differences were of lower magnitude than those between CD5^hi^ and CD5^lo^ populations (compare [Figs. 3A,B and F](#F3){ref-type="fig"}), arguing against the hypothesis that a small subset of CD5^hi^ cells accounts for all the enhanced reactivity of this population.

Aside from TCR signals, CD8^+^ T cell responses are strongly influenced by cytokines. Naïve CD5^hi^ CD8^+^ T cells are more reactive to γ~c~ cytokines^[@R24],[@R26]^ and possess enhanced ability to produce IL-2 following TCR stimulation^[@R11]^, which might induce autocrine IL-2R signaling. Also, the capacity of inflammatory cues to augment the magnitude of CD8^+^ T cell responses involves sustained upregulation of CD25 (ref^[@R38]^). To test whether CD25 expression impacts the differential response of CD5^lo^ and CD5^hi^ naïve CD8^+^ T cells, we assessed reactivity of CD25-deficient polyclonal CD8^+^ T cells, generated in mixed bone marrow chimeras, to avoid the lymphoproliferation and autoimmunity that occurs in CD25-deficient mice^[@R39]^. The distribution of CD5 expression was similar in wild-type and *Cd25*^−/−^ resting naïve CD8^+^ T cells ([Supplementary Fig. 3i](#SD1){ref-type="supplementary-material"}). As expected, the B8R/K^b^-specific wild-type CD5^hi^ population expanded more than wild-type CD5^lo^ cells ([Fig. 3g](#F3){ref-type="fig"}) but, while CD25 deficiency did not have a statistically significant effect on the response by B8R/K^b^-specific CD5^lo^ cells, the response by *Cd25*^−/−^ CD5^hi^ cells was modestly but significantly impaired ([Fig. 3g](#F3){ref-type="fig"}). While these data suggest the CD5^hi^ pool may be more reliant on IL-2 responsiveness, the responses of CD5^hi^ and CD5^lo^ cells were not normalized by CD25 deficiency, indicating that elevated IL-2 sensitivity cannot fully account for the differences between these populations.

Together these data indicate that the antigen specific response to pathogens is dominated by CD5^hi^ naïve CD8+ T cells.

Distinct clonal responses by CD5^hi^ and CD5^lo^ CD8^+^ T cells {#S5}
---------------------------------------------------------------

Our analysis of bulk naive CD8^+^ T cell responses could not determine whether the differential expansion of CD5^hi^ and CD5^lo^ naïve CD8^+^ T cell populations reflected enhanced responses by all antigen reactive CD5^hi^ cells, or dominance by a small number of CD5^hi^ CD8^+^ T cell clones. This is relevant because expansion characteristics of individual antigen specific naïve T cells can vary considerably^[@R2],[@R4],[@R40]--\ [@R42]^. Accordingly, we reduced the number of adoptively transferred naïve CD44^lo^ CD5^hi^ or CD5^lo^ polyclonal naïve CD8^+^ T cells to 25--30 × 10^3^ cells. Based on the frequency of B8R/K^b^ specific precursors^[@R35]^, 20% engraftment would seed \~1 B8R/K^b^ specific donor CD8^+^ T cell per 3--5 donor cell cohorts, giving an average predicted response rate of \~27.5%. To increase the efficiency of detecting a clonal response, we used simultaneous transfer of up to 8 congenically distinct donor populations into a single recipient, as described by others^[@R2],[@R4],[@R40]^ ([Supplementary Fig. 4](#SD1){ref-type="supplementary-material"}). Using CD5^hi^ naïve CD8^+^ T cells, \~ 24% (46/188) of transfers led to a B8R/K^b^ specific response, which was not significantly different from the predicted frequency ([Fig. 4a](#F4){ref-type="fig"}) and consistent with studies using naïve OT-I T cells^[@R40]^. In contrast, adoptive transfer of 25 × 10^3^ CD5^lo^ cells led to no detectable B8R/K^b^ specific donor responses (0/40), significantly below the predicted rate (see legend to [Fig. 4a](#F4){ref-type="fig"}). Increasing the input of CD5^lo^ donor cells to 100 × 10^3^ led to detectable responses, but only in 14% (18/125) of transfers ([Fig. 4a](#F4){ref-type="fig"}). This response rate suggests that less than 1/7^th^ the expected number of CD5^lo^ CD8+ T cell precursors were capable of mounting a detectable response. Examining non-clonal responses by 375 × 10^3^ CD5^hi^ or CD5^lo^ donor cells showed that \>95% of CD5^hi^ (23/24) but only 70% of donor CD5^lo^ populations (14/20) mounted a response ([Fig. 4b](#F4){ref-type="fig"}), further demonstrating the reduced response rate in the CD5^lo^ pool.

Furthermore, the mean clonal expansion magnitude ("burst size") of the responding CD5^lo^ population (from the 100 × 10^3^ cell transfer) was significantly smaller than that of CD5^hi^ cells (25--30 × 10^3^ cell transfer)([Fig. 4b](#F4){ref-type="fig"}). It was also notable that the two largest clonal responses were seen for cells derived from CD5^hi^ precursors, and were 10--100 fold greater than the largest CD5^lo^ clonal response (arrows in [Fig. 4B](#F4){ref-type="fig"}): Modeling the outcome if all the measured CD5^hi^ and CD5^lo^ clonal responses had occurred in a single animal, those two clones would account for nearly 80% of the B8R/K^b^ specific population (data not shown).

Hence, clonal analysis revealed two ways in which the CD5^hi^ and CD5^lo^ T cell responses differ: First, the CD5^hi^ population displayed a markedly greater response rate. Second, even among cells that did engage in the B8R/K^b^ specific response, the average burst size of the CD5^lo^ pool was reduced compared to CD5^hi^ responders. Together, these differences can account for much of the expansion advantage of the CD5^hi^pool.

Efficient recruitment of CD5^hi^ CD8+ T cells into the immune response {#S6}
----------------------------------------------------------------------

The increased clonal recruitment of CD5^hi^ versus CD5^lo^ cells might reflect preferential initial activation of CD5^hi^ cells, or similar initial response by both populations, followed by improved proliferation/survival of the CD5^hi^ population. The superior response by CD5^hi^ cells was already apparent at days 3--4 of the *in vivo* response to LM-B8R ([Fig. 5a](#F5){ref-type="fig"}), hence we next investigated whether CD5^hi^ cells were preferentially activated during the initial response to infection. This was not feasible using adoptive transfer of polyclonal cells, and to determine the response of endogenous CD5^hi^ and CD5^lo^ cells it was first necessary to test whether CD5 expression changes during short term *in vivo* activation. Nur77^gfp^ mice were injected with anti-CD3 i.v., and 5h later T cell activation was determined by induction of CD69 and Nur77^gfp^. Despite robust activation, naïve CD8+ T cells showed no change in CD5 expression ([Fig. 5b,c](#F5){ref-type="fig"}), indicating that CD5^hi^ and CD5^lo^ naïve populations could still be distinguished. Next, Nur77^gfp^ mice were infected with LM-B8R and 5h later splenic CD8^+^ T cells specific for B8R/K^b^ and for an irrelevant antigen (M57/K^b^ with the murine cytomegalovirus (MCMV) epitope, M57) were enriched using MHC class I tetramer capture. Following LM-B8R infection, activated naïve CD8^+^ T cells were evident among the B8R/K^b^--specific population but not in the control M57/K^b^-specific population ([Fig. 5d](#F5){ref-type="fig"}), and the activated B8R/K^b^--specific population was enriched for CD5^hi^ cells ([Fig. 5e,f](#F5){ref-type="fig"}). These data suggest that initial recruitment and/or activation favors the CD5^hi^ naïve CD8+ T cell pool during the response to foreign antigen.

CD5^lo^ and CD5^hi^ cells show similar foreign pMHC binding characteristics {#S7}
---------------------------------------------------------------------------

Some studies suggest CD5 expression on naïve TCR transgenic CD4^+^ T cells correlates with the TCR affinity for foreign-pMHC ligands, indicated by increased pMHC tetramer labeling of CD5^hi^ versus CD5^lo^ clones^[@R9]^. However, we found comparable pMHC tetramer staining intensities were observed on CD5^hi^ and CD5^lo^ naïve CD8+ T cell populations isolated by tetramer enrichment from unimmunized mice, ([Fig. 6a](#F6){ref-type="fig"}), suggesting similar capacities for foreign-pMHC ligand binding. Furthermore, B8R/K^b^ tetramer geometric mean fluorescence intensity (gMFI) was not significantly different on effector cells derived from clonal CD5^lo^ and CD5^hi^ responses revealed that intensity did not significantly differ for antigen-specific progeny of CD5^lo^ versus CD5^hi^ clones, whereas the burst size of CD5^hi^ clones was significantly higher than that of CD5^lo^ clones ([Fig. 6b](#F6){ref-type="fig"}). Thus, we observed minimal correlation between pMHC tetramer-staining intensity and either CD5 expression or clonal expansion characteristics of specific CD8^+^ T cells.

It was also possible that foreign antigen specific T cells are selectively under-represented in the CD5^lo^ pool. We did observe modest, but in some cases significant, skewing to higher CD5 expression within the foreign-pMHC tetramer binding naïve CD8^+^ T cell pool ([Fig. 6c](#F6){ref-type="fig"}), and accordingly there were slightly more B8R/K^b^ specific cells in sorted CD5^hi^ versus CD5^lo^ populations ([Supplementary Fig. 5](#SD1){ref-type="supplementary-material"}). However, such skewing only contributed an average \~1.5-fold increase in antigen-specific precursors within the CD5^hi^ population, relative to CD5^lo^ cells, which could not explain the larger differences in clonal recruitment or population expansion of antigen specific CD5^hi^ versus CD5^lo^ cells ([Figs. 3](#F3){ref-type="fig"},[4](#F4){ref-type="fig"}).

To avoid potential artifacts from the tetramer enrichment protocol, we analyzed four TCR transgenic lines which differ in CD5 surface expression, following the order H-Y \< F5 \< P14 \< OT-I^[@R22],[@R23],[@R26]^ ([Fig. 6d](#F6){ref-type="fig"}). All the TCR transgenic strains bound cognate pMHC tetramers with similar efficiency in dose titration ([Fig. 6e](#F6){ref-type="fig"}) indicating that, in contrast to studies with CD4^+^ TCR-transgenic T cells^[@R9]^, CD5^lo^ versus CD5^hi^ expression did not predict the strength of foreign-pMHC ligand binding to TCR-transgenic CD8^+^ T cells. Interpreting tetramer staining may be complicated by the finding that CD8 and TCR expression are reduced on naïve CD5^hi^ versus CD5^lo^ CD8^+^ T cells ([Supplementary Fig. 1a](#SD1){ref-type="supplementary-material"}), and CD8 contributes to Class I pMHC tetramer binding^[@R43]^. Hence we also tested reactivity (as CD69 induction) of CD5^hi^ and CD5^lo^ TCR transgenic T cells to their cognate foreign ligands in dose titration. Although differences in antigen sensitivity were seen, they did not correlate with CD5 expression levels ([Fig. 6f](#F6){ref-type="fig"}): for example CD5^hi^ OT-I and CD5^lo^ F5 CD8^+^ T cells showed similar antigen sensitivity. Instead, dose sensitivity corresponded with peptide binding to the relevant MHC molecules ([Fig. 6g](#F6){ref-type="fig"}). Hence, these data indicate that CD5 expression predicted neither tetramer binding nor in vitro antigen sensitivity of naïve CD8^+^ T cells.

An expectation from our findings would be that CD5^hi^ and CD5^lo^ naïve CD8^+^ T cells with identical TCRs would display distinct response characteristics. This hypothesis was supported by earlier studies using TCR transgenic CD8^+^ T cells sorted into CD5^hi^ and CD5^lo^ pools^[@R24]^, but as CD5 levels are typically determined during thymic development, we sought to manipulate positive selection to produce cells with distinct CD5 expression levels. Bone marrow chimeras were generated using OT-I TCR transgenic donor marrow to reconstitute wild-type or β2m^−/−^ hosts -- in the latter, positive selection is mediated by hematopoietic cells, resulting in generation of OT-I cells with lower CD5^lo^ expression ([Fig. 6H](#F6){ref-type="fig"} and data not shown). When assessed for their response to LM-OVA infection, CD5^hi^ OT-I expanded \~3--4-fold greater than the CD5^lo^ OT-I population ([Fig. 6I](#F6){ref-type="fig"}) indicating that CD5 expression levels correlated with the magnitude of the immune response, even when TCR specificity was normalized. In aggregate, our data suggest that the advantage of CD5^hi^ over CD5^lo^ naïve CD8^+^ T cells in their response to foreign antigen cannot be explained by differences in precursor frequency or avidity for foreign pMHC ligands.

Naïve CD5^hi^ cells utilize inflammatory signals during the response to antigen {#S8}
-------------------------------------------------------------------------------

Besides TCR signals, the magnitude of the CD8^+^ T cell response is influenced by inflammatory cues^[@R44],[@R45]^, hence we next tested the impact of inflammation on the response of CD5^hi^ and CD5^lo^ naïve CD8^+^ T cells. Since CD8^+^ T cell expansion is reduced in the absence of innate cues^[@R46],[@R47]^ this system was not suitable for analysis of rare antigen-specific polyclonal CD8^+^ T cells, hence we used H-Y and OT-I TCR transgenic T cells models as examples of CD5^lo^ and CD5^hi^ clones, respectively. Low numbers of naïve H-Y and OT-I CD8^+^ T cells from were transferred into congenic hosts and stimulated by injection of dendritic cells (DCs) loaded with cognate peptides, with or without co-infection using wild-type ΔactA LM, which expresses no stimulatory antigens for either TCR transgenic, as a source of inflammatory stimulation. OVA peptide was used to stimulate OT-I cells, while H-Y T cells were stimulated with C2A, a variant of the Smcy peptide that enhances HY TCR recognition without altering MHC binding^[@R48]^ ([Supplementary Fig. 6a--c](#SD1){ref-type="supplementary-material"}), to minimize differences in ligand dose sensitivity of H-Y and OT-I T clones.

As expected, antigen-bearing DCs alone provoked modest responses by both H-Y and OT-I cells ([Fig. 7a](#F7){ref-type="fig"}) and, when corrected for donor cell engraftment, there was moderately increased expansion of the OT-I versus H-Y pool ([Fig. 7b](#F7){ref-type="fig"}). LM co-infection enhanced expansion by the OT-I population, as anticipated from earlier studies^[@R38],[@R49]^, but did not increase H-Y T cell expanasion, and in fact caused a slight reduction in cell numbers ([Fig. 7a](#F7){ref-type="fig"}). Accordingly, LM co-infection greatly increased the difference between HY and OT-I population sizes ([Fig. 7b](#F7){ref-type="fig"}). Similar effects were seen using LCMV co-infection ([Fig. 7c,d](#F7){ref-type="fig"}) and preliminary studies using co-administration of the TLR9 agonist CpG yielded comparable results ([Supplementary Fig. 6d](#SD1){ref-type="supplementary-material"}). These data suggest that, while the CD5^hi^ clone OT-I responds to pro-inflammatory signals with enhanced expansion, this pathway is not operative for CD5^lo^ H-Y CD8^+^ T cells. The pro-inflammatory cytokines IL-12 and Type-I IFN act as a "3^rd^ signals" to promote CD8^+^ T cell responses^[@R46],[@R47]^, but preliminary *in vitro* experiments did not suggest differences in the responses of HY and OT-I T cells to those cytokines (data not shown), indicating a more complex basis for the altered response. Nevertheless, our data suggest qualitative differences in the response of CD5^hi^ versus CD5^lo^ CD8^+^ T cells when foreign antigen stimulation is delivered in the context of innate immune cues *in vivo*.

Discussion {#S9}
==========

Our data show that naïve CD8^+^ T cells with heightened recognition of self-pMHC ligands display enhanced reactivity toward foreign pMHC antigens. We confirmed and extended the utility of CD5 expression as a measure of the strength of self ligand encounter -- showing that CD5^hi^ cells exhibited increased expression of the Nur77-GFP reporter (a surrogate for TCR signaling) and changes in gene expression indicative of enhanced response sensitivity. Comparison of the *in vivo* response to foreign antigen revealed multiple steps at which the CD5^hi^ population of naïve CD8^+^ T cells manifest an advantage over their CD5^lo^ counterparts: initial activation and response rates were more efficient, the clonal burst size greater, and sensitivity to inflammatory cues enhanced. On the other hand, we did not observe a consistent difference in the capacity of polyclonal or TCR transgenic CD5^hi^ versus CD5^lo^ cells to bind to foreign pMHC tetramers, nor did TCR transgenic models suggest a difference in foreign pMHC response sensitivity. Taken together, our studies support a model in which the differences between CD5^hi^ and CD5^lo^ naïve CD8^+^ T cells are established prior to encounter with foreign antigen, and that numerous properties of the CD5^hi^ population make their responses more efficient and competitive.

Our data differ from two elegant reports that used CD5 expression to characterize heterogeneity in the naïve CD4 T cell response. While one study found that CD5^hi^ cells had enhanced TCR engagement with foreign pMHC ligands and superior response to antigen in vivo^[@R9]^, another reported that CD5^lo^ and CD5^hi^ cells had similar engagement with pMHC ligands and that CD5^lo^ cells showed greater in vivo expansion than their CD5^hi^ counterparts^[@R10],[@R11]^. Although we observed some skewing in the size of the foreign pMHC tetramer binding population in favor of the CD5^hi^ pool, this effect was modest and average tetramer binding intensity was similar for antigen specific CD5^lo^ and CD5^hi^ cells. Hence, our data and others^[@R10],[@R11]^ argue against the conceptually complex model that the structural capacity to bind foreign pMHC ligands is dictated by T cell sensitivity toward self-pMHC molecules. These discrepancies may reflect distinct properties of CD4 and CD8^+^ T cells (as discussed^[@R9]^), although this argument does not pertain to the divergent conclusions reached with studies on CD4 T cells^[@R9],[@R11]^. In any case, our findings reinforce the concept that, at least for naïve CD8^+^ T cells, the distinct responses of the CD5^hi^ and CD5^lo^ population likely reflects pre-existing, intrinsic properties of the cells, rather than arising from differences in foreign antigen perception.

Contrasting with our findings and others^[@R9]^, some reports found that CD5^lo^ cells expanded more effectively than CD5^hi^ cells, despite similar foreign ligand recognition properties^[@R10],[@R11]^. Significantly, recent studies argued that CD5^hi^ naïve CD4^+^ T cells exhibited a strong response to TCR stimulation, but this led to increased susceptibility for activation-driven cell death induced by IL-2^[@R11]^. Our data suggest that optimal expansion of activated CD5^hi^ naïve CD8^+^ T cells was dependent on CD25 expression, and enhanced IL-2 sensitivity (through improved CD122 signaling) was reported in the landmark studies of Cho et al. on of homeostasis of CD5^hi^ naïve CD8^+^ T cells^[@R24]^. Potentially, enhanced IL-2 sensitivity is a boon to responding CD5^hi^ CD8^+^ T cells, yet may be detrimental to CD5^hi^ CD4 T cells (at least in some situations) by making them more vulnerable to induced cell death. It is also worth noting that the range of CD5 expression levels (and associated basal TCR signaling) is greater in naïve CD4 T cells compared to naïve CD8^+^ T cells^[@R9]--[@R11]^, perhaps indicative of distinct functional thresholds between the subsets.

Our studies build on considerable work that suggested CD5 levels correlate with TCR engagement by self-pMHC^[@R9]--[@R11],[@R18]--[@R21]^. Our work defines the properties of the CD5^hi^ population prior to antigen encounter, and mechanisms with which these cells outcompete other naïve CD8^+^ T cell populations during an active immune response. It is unclear whether CD5 itself contributes to the distinct function of CD5^hi^ versus CD5^lo^ cells - recent studies using *Cd5*^−/−^ mice do not support that concept^[@R9],[@R11]^, although this does not negate the value of CD5 expression level as a marker. As we show here, the CD5^hi^ population differs from CD5^lo^ cells in their expression of several genes. However, even within the CD5^hi^ pool there is heterogeneity in T-bet, CXCR3 and induced XCL1 expression -- hence there may be other features of CD5^hi^ cells that better correlate with their improved functional prowess. We found a modest but significant advantage of CXCR3^hi^ CD5^hi^ over CXCR3^lo^ CD5^hi^ populations, suggesting CXCR3 expression may be a core feature of the optimal foreign antigen reactivity by CD5^hi^ naïve CD8^+^ T cells.

Together, these findings suggest that naïve CD8^+^ T cells with the greatest level of self-reactivity are the most efficiently recruited into the foreign-pMHC specific response. Since sensitivity to TCR signals may change following naïve T cell activation, it is possible that progeny of some CD5^hi^ clones could exhibit overt self-reactivity following activation, with significance for the induction of autoimmune disease following response to infection. At the same time, our findings leave open the question of why the CD5^lo^ pool is maintained in the naïve CD8^+^ T cell repertoire. CD5^lo^ cells are relatively resistant to deprivation of IL-7^[@R26]^, making it possible that these cells are efficiently maintained during naïve T cell competition for homeostatic cytokines. Alternatively, CD5^lo^ naïve CD8^+^ T cells may show superior responses to pathogens in certain situations: as shown for naïve CD4^+^ T cells heightened initial reactivity may accompany increased sensitivity to cell death^[@R10],[@R11]^. Whether some immune responses favor the CD5^lo^ population of naïve CD8^+^ T cells awaits further investigation.

METHODS {#S10}
=======

Mice {#S11}
----

We purchased 6- to 12-week-old female C57BL/6 and B6.SJL mice from the National Cancer Institute. For adoptive cell transfer recipients, we used F1 CD45.1/2 females generated from C57BL/6J (Jackson Laboratories) crossed with B6.SJL (NCI) mice. *Il15*^−/−^ and TCR-transgenic P14 mice^[@R51]^ were kind gifts from D. Masopust (University of Minnesota, Minneapolis, MN). P14 and OT-I^[@R52]^ and were maintained on a C57BL/6N and B6.PL (Thy-1.1) backgrounds. HY TCR transgenic mice were maintained on a *Rag2*^−/−^ background (apart from initial cell surface phenotype studies, in which cells from female *Rag2*^+/+^ HY mice were analyzed with the T3.70 monoclonal antibody to identify HY-specific CD8^+^ T cells). F5 *Rag1*^−/−^ mice were a kind gift of L. Cauley (University of Connecticut) and *Cd25*^−/−^ mice were obtained from Jackson Labs. The Nur77^gfp^ transgenic reporter mice have been previously described^[@R30]^, and were maintained on a C57BL/6N background. T-bet--ZsGreen reporter mice^[@R50]^ were initially obtained from J. Zhu (US National Institute of Allergy and Infectious Diseases, Bethesda, MD), and maintained on the C57BL/6N background. All mice were maintained in SPF conditions, and all mouse protocols were approved by the University of Minnesota Institutional Animal Care and Use Committee. No samples/animals were excluded from the analysis. The investigators were not blinded to group allocations or assessment.

Bacterial and Viral Infections {#S12}
------------------------------

ΔActA attenuated LM (DP-L1942)^[@R53]^ and ΔActA LM-OVA were provided by J. Harty (University of Iowa, Iowa City, IA) and LM-B8R (both virulent and ΔActA), which contains both the K^b^-restricted CD8^+^ epitopes B8R~20--27~ and OVA~257--264~ was a kind gift of R. Kedl (National Jewish Medical Research Center, University of Colorado, Denver, CO). LCMV Armstrong was a gift of D. Masopust. LM was grown in tryptic soy broth containing 50 μg/mL streptomycin to an OD~600~ of \~0.1. For primary infection with attenuated LM-B8R, 3 × 10^6^ CFU were injected intravenously (i.v.). For secondary infections with virulent LM-B8R, mice were injected with 1 ×10^6^ CFU i.v. In experiments where wild-type ΔActA LM was used to induce inflammation, 3--6 × 10^6^ CFU bacteria were mixed with peptide-pulsed DCs and co-injected i.v. For LCMV infections, mice were injected with 2 × 10^5^ PFU intraperitoneally.

Dendritic Cell Immunizations {#S13}
----------------------------

Splenic DCs were prepared as previously described^[@R49]^. Briefly, to generate splenic DCs, mice were injected s.c. with 5 × 10^6^ B16 cells expressing Flt3L (provided by M. Prlic and M. Bevan, University of Washington, Seattle, via J. Harty, University of Iowa). When tumors were palpable (5 × 5 mm), mice were injected with 2 μg LPS i.v. to mature the DCs and spleens were harvested \~16 h later. Following digestion with collagenase D for 20 min at 37°C, RBCs were lysed and splenocytes were resuspended in media comprised of 2 parts complete RPMI, 1 part B16-Flt3L-conditioned complete RPMI, 50 ng/mL GM-CSF, and 2 μM peptide. The C2A mutant of the SMCY peptide^[@R54]^ was used to stimulate HY CD8^+^ T cells, while OVA~257--264~ was used for stimulation of OT-I. Splenocytes were pulsed with peptide for 2 h at 37 °C, thoroughly washed, and DCs purified using Miltenyi CD11c microbeads. Mice were co-injected i.v. with 1 × 10^6^ DCs pulsed with each peptide, with co-administration of LM, LCMV or CpG as indicated.

Flow Cytometry {#S14}
--------------

Cells were stained with the following antibodies from eBioscience or BD Biosciences unless otherwise noted: CD4 (RM4-5), CD8^+^ (53--6.7), CD5 (53--7.3), CD27 (LG.7F9), CD44 (IM7), CD45.1 (A20), CD45.2 (104), Thy1.1 (HIS51 or OX-7), Thy1.2 (53--2.1), CD62L (MEL-14), CD69 (H1.2F3), CD122 (TM-b1), CD127 (A7R34), TCRβ (H57-597), CXCR3 (CXCR3-173), IFN-γ (XMG1.2), MHC class II (M5/114.15.2), and F4/80 (BM8). The B8R/K^b^ and OVA/K^b^ tetramers were generated as previously described^[@R43]^. The MCMV M57/K^b^, LCMV gp33/D^b^, influenza NP68/D^b^, and HY SMCY/D^b^ tetramers were provided by the NIH Tetramer Facility. For intracellular staining of transcription factors, cells were fixed and permeabilized with Foxp3 Fixation and Permeabilization Buffers (eBioscience) and stained with antibodies to T-bet (4B10) and Eomesodermin (Dan11mag) in Permeabilization Solution. Data was collected on LSR-II or Fortessa flow cytometers (BD Biosciences) and data were analyzed by using FlowJo analysis software (Tree Star).

XCL1 expression assay {#S15}
---------------------

Peripheral lymphocytes were stained with anti-XCL1 mAb (MTAC-2)^[@R55]^ that was kindly provided by R. Kroczek (Robert Koch-Institute, Berlin, Germany). To examine XCL1 production, bulk splenocytes were stimulated to PMA/ionomycin for 3--5 h at 37°C in the presence of Brefeldin A. Cells were stained for cell surface markers then fixed and permeabilized with BD Cytofix/Cytoperm or eBiosciences Foxp3/transcription factor fixation/permeabilization solutions, prior to intracellular staining for XCL1.

Cell Sorting and Adoptive Transfer {#S16}
----------------------------------

For adoptive transfer experiments, spleens and lymph nodes from C57BL/6 (CD45.2/2) and B6.SJL (CD45.1/1) mice digested with collagenase D (Roche) and negatively enriched for CD8^+^ T cells using Miltenyi enrichment antibody cocktail and beads. Cells were then stained with anti-CD8, CD5, and CD44 and CD8^+^CD44^lo^ cells (i.e. excluding CD44^hi^ cells) were sorted on the lower or upper 20% of CD5 expression using a BD FACSAria I. In some studies, the CD5^hi^ CD44^lo^ population was further gated on the lower or upper 30% of CXCR3 prior to sorting. Approximately 1.25--1.5 × 10^6^ each of congenically mismatched CD5^lo^ and CD5^hi^ cells were co-transferred into CD45.1/2 recipients and infected with LM-B8R in the next day. For recall experiments, CD5^lo/hi^ recipients that had been infected with ΔActA LM-B8R \>40 days previous were challenged with virulent LM-B8R. Varied combinations of congenic backgrounds for donor and host animals in transfer studies.

In experiments where we transferred single B8R/K^b^-specific CD8^+^ T cell clones, CD8^+^ T cells were negative enriched from the spleens and lymph node cells of 4 to 8 congenically distinct donors by using different combinations of CD45.1/2 and CD90.1/2 ([Supplementary Fig. 6](#SD1){ref-type="supplementary-material"}). Equal numbers of CD8^+^ T cells from each congenic donor group were mixed, stained with anti-CD8, CD5, and CD44 and sorted for naïve CD8^+^ T cells in the lower or upper 20% for CD5 expression. The indicated number of CD5^lo/hi^ cells for each congenic group was then transferred into congenic recipients. Mice were infected 1--2 days post-transfer with attenuated LM-B8R, and the response to B8R/K^b^ was assessed 7 days later. Background staining for congenic markers was very low (1 event or less, data not shown), and we set our limit of detection at ≥3 flow cytometric events in the antigen specific population, which equates to \~5 total B8R/K^b^ specific CD8^+^ T cells

In adoptive transfer experiments using TCR transgenic CD8^+^ T cells, CD44^lo^ Thy-1.1 OT-I cells (RAG^+/+^ or RAG-1^−/−^) were enriched by negative selection as previously described^[@R56]^. Female *Rag-2*^−/−^ HY CD8^+^ T cells, which are all CD44^lo^, were negatively enriched using Miltenyi beads. Mixtures containing 1000 each of the OT-I and HY populations were co-transferred i.v. into B6.SJL mice and these recipients were immunized 1 day later. To assess the "take", 2 × 10^5^ cells from the same mixture of OT-I and HY cells was transferred into recipients, cells from these mice were then analyzed by flow cytometry the day of immunization. Similar "take" ratios were observed when animals receiving 1000 OT-I and HY T cells were enriched using magnetic beads on the day of immunization (data not shown).

MHC Class I Tetramer Enrichment {#S17}
-------------------------------

To analyze CD8^+^ T cell antigen-specific precursors or CD5^lo/hi^ donor responses following infection, MHC class I tetramer enrichment was used as previously described^[@R35]^. Briefly, spleen and lymph nodes (for analyzing precursors) or spleen only (LM infection) were digested with collagenase D. Cells were labeled with PE- or APC-conjugated tetramers and enriched over magnetic columns using anti-PE or APC magnetic beads (Miltenyi). A small portion of the enriched fraction was added to AccuCheck counting beads (Invitrogen) to accurately back-calculate total numbers. Tetramer-enriched fractions were then stained with additional extracellular antibodies and fixed with paraformaldehyde prior to analysis by flow cytometry.

Mixed Bone-Marrow Chimeras {#S18}
--------------------------

We generated mixed bone-marrow chimeras by mixing T cell-depleted bone marrow from congenic strains and injecting 5--10 × 10^6^ cells into lethally irradiated (1000 rads) host animals. For chimeras with WT and *Cd25*^−/−^ bone marrow, roughly equal numbers of cells from CD45.1/2^+^ WT and CD45.2^+^ *Cd25*^−/−^ mice (6--8 weeks of age) were injected into CD45.1^+^ WT hosts. For OT-I chimeras, Thy-disparate OT-I (RAG^+^) bone marrow was injected into congenically distinct WT or *β2m*^−/−^ recipients. Cells from chimeras were used \>10 weeks after transplant.

*In vitro* Stimulation {#S19}
----------------------

To assess CD8^+^ T cell activation, 2×10^4^ purified CD44^lo^ CD8^+^ TCR transgenic cells were incubated at 37°C with 1--2×10^6^ splenic antigen presenting cells in 96-well round-bottom plates with titrated doses of cognate peptide: OT-I with K^b^/OVA~257--264~ (SIINFEKL), P14 with D^b^/gp~33--41~ (KAVYNFATC), F5 with D^b^/NP~366--374~ (ASNENMDAM), HY with D^b^/Smcy (KCSRNRQYL) or D^b^/C2A (KASRNRQYL). Cells were stimulated for 6 h and then stained for CD69 expression.

RMA-S MHC Class I Stabilization Assay {#S20}
-------------------------------------

RMA-S cells were cultured in RPMI containing 10% FCS at 30°C with 5% CO~2~ overnight. In a 96-well round-bottom plate 1 × 10^5^ RMA-S cells were incubated with titrated doses of peptide for 1 h and then the plate was moved to a 37 °C CO~2~ incubator for 3 h. Cells were then stained for stable surface class I molecules using H-2K^b^ (Y3) or H-2D^b^ (28.14.8) antibodies.

Gene Transcription Analysis {#S21}
---------------------------

Naïve CD44^lo^ CD8^+^ T cells from spleens and lymph nodes were flow sorted on the lower and upper 20% of CD5 expression as described above. For each sample ≥1 × 10^6^ cells were used for RNA extraction using a RNeasy microkit (Qiagen). RNA was used to generate biotinylated cRNA using the MessageAmpIII RNA Amplification kit (Ambion) following the manufacturer's recommendations. Samples were hybridized to Affymetrix murine 430 2.0 gene chips at the BioMedical Genomics Center (University of Minnesota) following standard procedures. RNA samples from three independent sorts were analyzed. Gene expression analysis that led to [Table 1](#T1){ref-type="table"} used Genespring software: Data were MAS5 normalized and filtered for present/absent calls in at least one group, and for stastically significant (*P* \< 0.05) fold change of \>2.0. For enrichment analysis ([Table 2](#T2){ref-type="table"}), cluster genes expressed by either CD5^hi^ or CD5^lo^ cells were determined to be any genes with a Fold Change (FC)\>0. Significance was determined by χ^2^ where equal distribution was taken as the null hypothesis. Histograms show fold change within the CD5^hi^ versus CD5^lo^ comparison, binned as indicated, for genes within the indicated clusters.

Statistics {#S22}
----------

Unless indicated otherwise in the figure legend, a two-tailed, unpaired Student's *t* test was performed on log-transformed data using Prism (GraphPad Software). When making multiple comparisons, one-way ANOVA with Dunnett's Multiple Comparison post-test was used. Sample sizes were chosen based on previous experience and similar studies. In the clonal analysis shown in [Fig. 4](#F4){ref-type="fig"}, the data distribution was not normal or lognormal, and the non-parametric Mann-Whitney test was applied. The *P* values are indicated with asterisks, defined in each figure legend.
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![CD5 expression by naïve CD8^+^ T cells identifies stable populations with unique phenotypic traits\
Flow cytometry of cells combined from spleen and lymph nodes of wild-type (**a**) or *Il15*^−/−^ (**b**) mice were stained for CD44 and CXCR3 and transcription factors T-bet and Eomes. Data were gated on naive (CD44^lo^ CD122^lo^) CD8^+^ T cells in the lowest 20% (red) and highest 20% (blue) with respect to CD5 expression. Memory phenotype (MP) cells (CD44^hi^CD122^hi^) are indicated as gray shaded histograms. Data represent expression of indicated molecules and forward scatter (as a measure of cell size). (**c,d**) Naïve CD8^+^ T cells were sorted on CD5 expression as indicated and congenic populations co-transferred into normal recipient mice, which were analyzed 4--8 weeks later without immunization. Representative data are shown for the histograms (**c,d**); **d**, right, summary of compiled data (each symbol represents an individual mouse). (**e,f**) Flow cytometry of CD4^+^ CD25^--^ and CD8^+^ T cells from Nur77^gfp^ transgenic mice. T cells were gated on the lower or upper CD5 expression and analyzed for GFP expression (**e**). MP cells (gray) are included for comparison. In (**f**) flow cytometry of HY or OT-I TCR transgenic CD8^+^ T cells, gated on the CD44^lo^ population, for CD5 and Nur77^gfp^ expression as compared to polyclonal naïve CD8^+^ T cells (gray). Data in (a,c,d) are representative of 4 independent experiments (a n=10; c,d n=9), in (b,f) 2 independent experiments (b n=4; f n=6--7) and in (e) 3--4 independent experiments (n=6--11).](nihms638367f1){#F1}

![Naïve CD5^lo^ and CD5^hi^ CD8^+^ T cells have distinct gene-expression characteristics\
(**a,b**) Expression of XCL1, CXCR3 and T-bet by naïve (CD44^lo^) CD8^+^ T cells in the highest 20% (CD5^hi^) or lowest 20% (CD5^lo^) with respect to CD5 expression and memory phenotype (CD44^hi^) CD8^+^ T cell populations. (**a**) Splenocytes were stimulated with PMA/ionomycin in the presence of brefeldin A and then stained intracellularly for XCL1. Grey histograms represent unstimulated cells, solid lines indicate stimulated cells. (**b**) Frequencies of indicated subsets expressing XCL1, CXCR3 or T-bet. Expression of XCL1 was determined following activation (as in (a)), while CXCR3 and T-bet expression was determined in unstimulated B6 or T-bet reporter mice^[@R50]^. **(c)** CD44^lo^ CD8^+^ T cells were flow sorted on the lower/upper 20% of CD5 expression and mRNA from 3 individual sorts was isolated and analyzed using an Affymetrix gene array. Differences between CD5^lo^ and CD5^hi^ transcription were compared against gene clusters associated with stages of the in vivo CD8^+^ T cell response^[@R34]^. Histograms represent fold-change ratio for expression in CD5^lo^ versus CD5^hi^ cells of genes from clusters II, III and X, revealing preferential expression in the CD5^hi^ population (indicated as a fold change ratio \<1). Data in (a) are representative of 4 experiments (9 mice); data in (b) were compiled from: 4 experiments (n=9) for XCL1; 3 experiments (n=7) for T-bet; 5 experiments (n=13) for CXCR3. Data in (c) derive from analysis of gene array analysis from 3 independent cell sorting experiments. \* indicates p\<0.001](nihms638367f2){#F2}

![Naïve CD5^lo^ and CD5^hi^ CD8^+^ T cell precursors differ in their capacity to respond to foreign antigen\
CD44^lo^ CD8^+^ T cells in the lowest or highest 20% for CD5 expression were sorted and 1.25--1.5 × 10^6^ each of congenically distinct CD5^lo^ and CD5^hi^ cells co-transferred into CD45.1/CD45.2 host animals, which were infected the next day with LM-B8R. B8R/K^b^--specific cells were isolated from the spleen by B8R/K^b^ tetramer enrichment at the indicated time points. (a) shows the ratio of donor CD5^hi^ and CD5^lo^ B8R/K^b^-specific cells at days 7 and 30 after primary LM-B8R infection or 5 days after re-challenge of memory recipients with virulent LM-B8R, while (b) shows total donor cells number for the d7 timepoint. Each dot is a host animal. Filled symbols in (a) indicate mice where a B8R/K^b^-specific response was not detected for CD5^lo^ donor cells -- the CD5^hi^/CD5^lo^ ratio was arbitrarily set to 100. The double dagger symbol (‡) indicates an outlier: exclusion of this group did not alter the statistical significance shown in (b). (c) The ratio of bulk LM-specific donor CD5^hi^/CD5^lo^ CD8^+^ T cells from the experiments shown in (a). Data in (a,c) are shown as the geometric mean ± 95% confidence interval. (d,e) Total CD8^+^ CD44^lo^ cells were sorted and combined with congenically distinct CD44^lo^ CD5^lo^ or CD44^lo^ CD5^hi^ populations and 1.25 -- 1.5 × 10^6^ of each population co-transferred into congenic recipients which were infected with LM-B8R 1d later. The B8R/K^b^-specific (d) and bulk LM-specific (e) responses were determined 7d after infection. The graphs indicate mean ± SEM. (f) CD5^hi^ naïve CD8^+^ T cells (CD44^lo^ cells in the upper 20% for CD5 expression) were sorted into the lowest or highest 30% for CXCR3 expression. 1--2×10^6^ of congenically distinct CXCR3^lo^ and CXCR3^hi^ CD5^hi^ cells were co-transferred into CD45.1/45.2 donors, and infected 1d later with LM-B8R. B8R/K^b^-specific cells were isolated from the spleen 7d after infection by tetramer enrichment. The upper panel shows the ratio of cells derived from CXCR3^hi^ versus CXCR3^lo^ donor cells in the B8R/K^b^-specific and bulk LM-B8R responsive populations. The lower panel shows the number of B8R/K^b^--specific CXCR3^hi^ and CXCR3^lo^ donor cells isolated. The geometric mean is indicated. (g) Mixed bone marrow chimeras were generated using congenic wild-type and *Cd25* (IL-2Rα)-deficient bone marrow. Following T cell reconstitution, CD44^lo^ CD5^lo^ and CD5^hi^ populations were sorted and congenically distinct combinations of WT and KO cells co-transferred into congenic recipients that were infected with LM-B8R 1d later. At d7 following infection, the spleen was recovered and the number of B8R/K^b^--specific donor cells enumerated. Data show the geometric mean ± 95% confidence interval. In all figures, each symbol indicates data from a single animal. Data in (a-c) are compiled from four experiments at day 7 (n = 11), 3 experiments at day 30 (n = 9), and 2 experiments for day 5 recall (n = 6); (d) shows data compiled from 3 experiments (n = 11--12 mice), (e) from two experiments (n = 8); (f) is compiled from 3 experiments (n=10); (g) is compiled from 3 individual experiments (n = 6). For this figure, statistical analysis is indicated as follows: \*\*\* for p \< 0.001; \*\* for p \< 0.01; \* for p \< 0.05.](nihms638367f3){#F3}

![Analysis of clonal naïve CD5^lo^ and CD5^hi^ CD8^+^ T cell responses to infection\
The indicated number of sorted CD5^lo^ or CD5^hi^ cells was transferred into congenic recipients and the B8R/K^b^-specific donor-derived response was determined in the spleen 7 days after infection with LM-B8R. (The congenic marker scheme used is illustrated in [Fig. S4](#SD1){ref-type="supplementary-material"}).\
(a) Response rate for the indicated number of transferred donor cells for which a B8R/K^b^-specific response was observed above the limit of detection (5 cells). Error bars are calculated standard deviation. Statistical analysis using a one-sided binomial test showed that the response rate for 2.5×10^4^ and 1×10^5^ CD5^lo^ cells (0/40 and 18/125, respectively) were significantly different from that expected (25% and 100%, respectively) (p\<0.0001 for both) while the response rate for 2.5--3.0 × 10^4^ CD5^hi^ cells was not significantly different from average expected rate (\~27.5%) (p=0.2). (b) Numbers of B8R/K^b^-specific CD8^+^ T cells derived from each donor population, shown as the geometric mean ± 95% confidence interval. Each symbol represents cell numbers from an individual donor cohort. Donor populations that did not mount a detectable response are shown on the limit of detection line. Two very large clonal responses are indicated by arrows. Host responses are shown for comparison. Statistical significance was assessed only on responses above the limit of detection, using the Mann-Whitney test on log-transformed values. The numbers of transferred cohorts for each condition is given in the text, and the data derive from 2--4 separate experiments. The symbol \* indicates p\<0.05.](nihms638367f4){#F4}

![Early recruitment of CD5^lo^ and CD5^hi^ cells into the immune response after infection\
(a) Congenically distinct CD44^lo^ CD5^lo^ and CD5^hi^ cells were sorted and co-transferred into congenic recipients as in [Fig. 3](#F3){ref-type="fig"}. Donor-derived B8R/K^b^-specific responses were analyzed from the spleen on day 3 or 4 after infection with LM-B8R. Data are shown as the geometric mean ± 95% confidence interval. (b,c) Nur77^gfp^ transgenic mice were injected i.v. with 50 μg anti-CD3 or PBS and spleens harvested 5 hrs later. Representative data is shown for expression of Nur77^GFP^ and CD69 (b) and CD5 levels (c) on CD44^lo^ CD8^+^ T cells. (d-f) Nur77^gfp^ transgenic mice were infected with 1 × 10^7^ CFU LM-B8R and spleens harvested 5h later. B8R/K^b^- and M57/K^b^-specific CD8^+^ T cells were isolated by tetramer based enrichment. (d) Nur77^gfp^ and CD69 expression was assessed on B8R/K^b^- and M57/K^b^-specific CD8^+^ T cells, and (e) B8R/K^b^-specific cells with activated (Nur77^gfp-hi^, CD69^+^) and non-activated (Nur77^gfp-lo^, CD69^−^) phenotype assessed for CD5 expression. (d,e) are representative data. (f) shows normalized geometric mean fluorescence intensity (gMFI) for CD5 expression on non-activated and activated B8R/K^b^ specific naïve CD8^+^ T cells. (a) shows data compiled from a total of 3 experiments (1 at day 3; n=5, 2 at day 4; n=9); Data in (b,c) are from 2 separate experiments (n=3); (d--f) show representative or compiled data from 3 experiments (n=13) for B8R/K^b^--specific cells and 2 experiments (n=9) for M57/K^b^--specific cells. \* indicates p \< 0.01.](nihms638367f5){#F5}

![CD5^hi^ and CD5^lo^ cells show similar TCR binding to cognate antigen\
(a) B8R/K^b^ and M57/K^b^ specific CD8^+^ T cells were enriched from unimmunized mice and CD44^lo^ precursors were gated on the lower and upper 20% of CD5 expression. Tetramer staining intensity (gMFI) was determined for both groups and expressed as a ratio, to normalize between experiments. (b) B8R/K^b^ tetramer staining (gMFI) and burst size of expanded clonal populations derived from CD5^lo^ and CD5^hi^ donor cells at d7 following LM-B8R infection. Data derive from transfers of 1×10^5^ CD5^lo^ and 2.5--3.0 × 10^4^ CD5^hi^ cells (see [Fig. 4](#F4){ref-type="fig"}). Tetramer gMFI on donor cells was normalized to tetramer gMFI on host B8R/K^b^-specific cells from the same mice, to yield relative fluorescence intensity (RFI). (c) Spleen and lymph node cells from unimmunized mice were subjected to tetramer enrichment. CD5 expression as gMFI on B8R/K^b^-specific and M57/K^b^-specific CD44^lo^ CD8^+^ T cell populations was compared to normalized CD5 expression on bulk CD44^lo^ CD8^+^ T cells. (d) CD5 expression levels on indicated MHC class I-restricted TCR transgenic CD8^+^ T cells. The histograms shows representative data while the bar graph shows CD5 relative fluorescence intensity (RFI), CD5 staining on polyclonal B6 CD44^lo^ CD8^+^ T cells being set at "100". (e) MHC class I tetramer binding to TCR transgenic cells after staining with the indicated range of tetramer concentrations. RFI reflects the geometric MFI of tetramer staining normalized to maximum intensity, which was set at "100". Similar data were obtained in a second experiment. (f) In vitro activation of TCR transgenic CD8^+^ T cells. T cells were incubated with titrated doses of peptide for 6 hrs and CD69 expression was assessed by flow cytometry. Data are normalized to maximum CD69 expression. Similar data were obtained in a repeat experiment. (g) Expression of K^b^ or D^b^ on RMA-S cells following incubation with indicated doses of the peptides recognized by studied TCR transgenic T cells. RFI reflects the MFI of Class I MHC molecule staining, normalized to maximum intensity, which was set at "100". Data are representative of three experiments. (h) OT-I bone marrow chimeras were generated by transferring OT-I bone marrow (RAG^+^) into irradiated WT or β2m^−/−^ hosts. Flow plots showing CD5 expression is representative of 4 separate sets of chimeras. Congenically distinct CD44^lo^ OT-I CD8^+^ T cells were enriched from each chimera source and 10^3^ cells of each population co-transferred into congenic recipients that were untreated or infected 1-3d later with attenuated ΔActA LM-OVA. (i) Donor cell engraftment ("take") was determined uninfected recipients, and compared to ratios of donor-derived populations at 7d and 12d after LM-OVA infection. Data are shown as mean ± SEM.\
In (a) data are compiled from 4 experiments (n = 14 for B8R/K^b^, n = 9 for M57/K^b^); (b) data are from 18 (CD5^lo^) and 46 (CD5^hi^) clonal responses from at least 3 experiments. \* indicates p\<0.05. Statistical significance was not changed by exclusion of the outlier (marked as ‡); In (c) the data is compiled from 6 experiments (n = 21) for B8R/K^b^-specific cells and two experiments (n = 8) for M57/K^b^-specific cells. \*\*p \< 0.001. In (d) data are compiled from 2--3 experiments (n=4--6); (e,f,g) are representative of 2--3 independent experiments; (h,i) Data are representative or compiled from 4 independent sets of chimeras.](nihms638367f6){#F6}

![CD5^hi^ cells preferentially utilize pro-inflammatory signals during expansion\
Congenically distinct CD44^lo^ H-Y and OT-I TCR transgenic CD8^+^ T cells were co-transferred into congenic recipients. Mice were co-immunized the next day with single peptide-pulsed matured DCs, with or without collateral infection with ΔactA^−/\ −^ LM (a,b) or LCMV Armstrong (c,d). (a,c) Show total numbers of splenic H-Y and OT-I CD8^+^ T cells 7d post-immunization with antigen pulsed DC, with or without indicated infections, while (b,d) shows ratios of OT-I/H-Y normalized to the "take" ratio observed in unimmunized animals 1d after adoptive transfer. All graphs show mean ± SEM. Data in (a,b) are compiled from 3 independent experiments (n=10); data in (c.d) are compiled from 2 experiments (n=6 for DC alone and n=7 for DC+LCMV). \* = p\<0.01; \*\* = p \<0.001.](nihms638367f7){#F7}

###### Major gene expression differences between sorted CD5^hi^ and CD5^lo^ naïve polyclonal CD8^+^ T cells

Gene expression analysis was performed as described in **Methods**, and genes that showed statistically significant (*P* \< 0.05), greater than 2-fold changes between the populations are indicated. Duplicates result from multiple probe sets for the same gene.

                      Gene Symbol       Fold change   *P*-value
  ------------------- ----------------- ------------- -----------
  **UP in CD5^hi^**                                   
  1                   A430093F15Rik     7.16          0.0170
  2                   Endod1            5.79          0.0233
  3                   Cxcr3             5.60          0.0217
  4                   A530021J07Rik     5.48          0.0033
  5                   Ly6C1             5.27          0.0200
  6                   Tbx21 (T-bet)     4.96          0.0019
                      *A530021J07Rik*   *4.74*        *0.0113*
                      *A530021J07Rik*   *3.66*        *0.0144*
  7                   Ndrg1             3.42          0.0224
  8                   Eomes             3.41          0.0255
  9                   Ighv14--2         3.28          0.0059
  10                  Cobll1            3.11          0.0033
  11                  Ms4a4c            3.08          0.0172
  12                  Reck              3.02          0.0201
  13                  Itih5             3.00          0.0391
  14                  Phactr2           2.97          0.0431
  15                  Bcat1             2.91          0.0122
  16                  Cldn10            2.88          0.0039
  17                  9230110F15Rik     2.85          0.0293
  18                  Serf1             2.76          0.0314
  19                  Ptgfrn            2.72          0.0458
  20                  Xcl1              2.70          0.0173
                      *Eomes*           *2.65*        *0.0361*
  21                  Plac8             2.60          0.0137
  22                  Rrm2              2.58          0.0286
  23                  Fahd1             2.52          0.0457
  24                  Mcart6            2.43          0.0019
                      *Ms4a4c*          *2.41*        *0.0179*
  25                  Ikzf2 (Helios)    2.40          0.0273
  26                  Xdh               2.40          0.0031
  27                  BB557941          2.40          0.0484
  28                  Cd200             2.27          0.0288
  29                  Anxa2             2.26          0.0213
                      *Ndrg1*           *2.23*        *0.0047*
  30                  Gsto1             2.21          0.0197
  31                  Cd5               2.20          0.0034
  32                  Ptpn4             2.20          0.0291
  33                  Chst11            2.17          0.0097
  34                  Armcx4            2.15          0.0115
  35                  Top2a             2.15          0.0321
  36                  Hopx              2.14          0.0143
                      *Ndrg1*           *2.12*        *0.0008*
  37                  Il10              2.10          0.0249
  38                  Stmn1             2.09          0.0357
  39                  Mrpl35            2.09          0.0337
  40                  Lilrb3 & Pira     2.08          0.0021
  41                  Coro2a            2.07          0.0034
  42                  Cd44              2.06          0.0072
  43                  Kctd15            2.03          0.0268
  44                  Pogk              2.03          0.0124
  45                  Id3               2.02          0.0049
  46                  Pck1              2.02          0.0151
  47                  Aim1              2.02          0.0227

                        Gene Symbol     Fold change   *P*-value
  --------------------- --------------- ------------- -----------
  **DOWN in CD5^hi^**                                 
  1                     Dntt            9.27          0.0110
  2                     Slc6a19         4.18          0.0025
                        *Slc6a19*       *4.10*        *0.0143*
  3                     Slc16a5         2.79          0.0257
  4                     Ddc             2.55          0.0035
  5                     A130038J17Rik   2.30          0.0175
  6                     Grik4           2.20          0.0034
  7                     Tmem154         2.10          0.0322
  8                     4930513N10Rik   2.08          0.0453
  9                     Tubb2a          2.03          0.0200
  10                    Itk             2.01          0.0411

###### 

Alignment between gene set expression differences for CD5hi and CD5lo naïve CD8+ T cells, and Immgen gene set clusters for CD8 T cell responses.

Gene set clusters and designated characteristics are listed (from ref^[@R34]^). The columns labeled "CD5^lo^" and "CD5^hi^" indicate the number of genes from each cluster that were preferentially expressed in that subset. The column labeled "Proportion" indicates the fraction of those genes expressed in the CD5^lo^ subset. The significance of differential expression was determined by χ^2^ test (see **Methods**), and are listed in the column labeled "P-values".

  Immgen Cluster   Characteristics                         CD5^lo^   CD5^hi^   P-value      Proportion
  ---------------- --------------------------------------- --------- --------- ------------ ------------
  Cluster I        Initial cytokine or effector response   12        22        0.086        0.352
  Cluster II       Preparation for cell division           187       334       1.193 E-10   0.358
  Cluster III      Cell cycle & division                   93        187       1.936 E-08   0.332
  Cluster IV       Naive and late memory                   51        40        0.248        0.560
  Cluster V        Early effector, late memory             54        72        0.108        0.428
  Cluster VI       Short-term effector and memory          27        37        0.211        0.421
  Cluster VII      Memory precursor                        61        49        0.252        0.554
  Cluster VIII     Naive or late effector or memory        129       138       0.581        0.483
  Cluster IX       Short-term effector or memory           39        55        0.098        0.414
  Cluster X        Late effector or memory                 34        59        0.009        0.365
